Enhancing the efficacy of immunotherapy using radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing the efficacy of immunotherapy using radiotherapy

Published:2020-01 Issue:9 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Keam Synat¹²^ORCID,Gill Suki³,Ebert Martin A³⁴^ORCID,Nowak Anna K¹²⁵^ORCID,Cook Alistair M¹²^ORCID

Affiliation:

1. National Centre for Asbestos Related Diseases Perth WA Australia

2. School of Medicine The University of Western Australia Perth WA Australia

3. Department of Radiation Oncology Sir Charles Gairdner Hospital Perth WA Australia

4. School of Physics, Mathematics and Computing The University of Western Australia Perth WA Australia

5. Department of Medical Oncology Sir Charles Gairdner Hospital Nedlands, Perth WA Australia

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1169

Reference145 articles.

1. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

3. Cold tumors: a therapeutic challenge for immunotherapy;Bonaventura P;Front Immunol,2019

4. Current strategies to enhance anti‐tumour immunity;Cook KW;Biomedicines,2018

5. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapy;European Journal of Pharmacology;2024-10

2. Epigenetic modification in radiotherapy and immunotherapy for cancers;Tzu Chi Medical Journal;2024-09-05

3. Biological Insights and Radiation–Immuno–Oncology Developments in Primary and Secondary Brain Tumors;Cancers;2024-05-28

4. Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models;Cell Death & Disease;2024-01-11

5. Manganese-based nanomaterials in diagnostics and chemodynamic therapy of cancers: new development;RSC Advances;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3